Canlyniadau Chwilio - David D. Thompson
- Dangos 1 - 20 canlyniadau o 21
- Ewch i'r Dudalen Nesaf
-
1
-
2
-
3
-
4
Prostaglandin E2 receptors in bone formation gan M. Li, David D. Thompson, Vishwas Paralkar
Cyhoeddwyd 2007Revisão -
5
-
6
-
7
-
8
-
9
Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Sca... gan Michael P. Whyte, Kenji P. Fujita, Scott Moseley, David D. Thompson, William H. McAlister
Cyhoeddwyd 2018Artigo -
10
Lasofoxifene (CP-336,156), a Selective Estrogen Receptor Modulator, Prevents Bone Loss Induced by Aging and Orchidectomy in the Adult Rat gan Hua Zhu Ke, Hong Qi, David T. Crawford, Kristin L. Chidsey-Frink, Hollis A. Simmons, David D. Thompson
Cyhoeddwyd 2000Artigo -
11
-
12
-
13
Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia gan Michael P. Whyte, Cheryl R. Greenberg, Keiichi Ozono, Richard J. Riese, Scott Moseley, Agustin Melian, David D. Thompson, Nicholas Bishop, Christine Hofmann
Cyhoeddwyd 2015Artigo -
14
Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family gan Vishwas Paralkar, Amy L. Vail, W A Grasser, Thomas A. Brown, Hong Xu, Slobodan Vukičević, Hua Zhu Ke, Hong Qi, Thomas A. Owen, David D. Thompson
Cyhoeddwyd 1998Artigo -
15
The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons gan David D. Thompson, J.G. Seedor, H. Quartuccio, Howard F. Solomon, Christine Fioravanti, James S. Davidson, Hilton J. Klein, Rod Jackson, J. Clair, D. Frankenfield, E. Brown, Hollis A. Simmons, Gideon A. Rodan
Cyhoeddwyd 1992Artigo -
16
Deletion of the P2X<sub>7</sub>Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and Resorption gan Hua Zhu Ke, Hong Qi, A. Frederik Weidema, Qing Zhang, Nattapon Panupinthu, David T. Crawford, W A Grasser, Vishwas Paralkar, Mei Li, Laurent Audoly, Christopher A. Gabel, W.S.S. Jee, S. Jeffrey Dixon, Stephen M. Sims, David D. Thompson
Cyhoeddwyd 2003Artigo -
17
Asfotase alfa therapy for children with hypophosphatasia gan Michael P. Whyte, Katherine L. Madson, Dawn Phillips, Amy Reeves, William H. McAlister, Amy Yakimoski, Karen Mack, Kim Hamilton, K. G. Kagan, Kenji P. Fujita, David D. Thompson, Scott Moseley, Tatjana Odrljin, Cheryl R. Greenberg
Cyhoeddwyd 2016Artigo -
18
Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women gan Andrea Z. LaCroix, TJ Powles, C. Kent Osborne, K. Wolter, John R. Thompson, David D. Thompson, D. Craig Allred, Roy A. Armstrong, S. R. Cummings, Richard Eastell, Kristine E. Ensrud, PE Goss, Andrew Lee, P. Neven, David M. Reid, Madelyn Curto, Slobodan Vukičević
Cyhoeddwyd 2010Artigo -
19
Lasofoxifene in Postmenopausal Women with Osteoporosis gan Steven R. Cummings, Kristine E. Ensrud, Pierre D. Delmas, Andrea Z. LaCroix, Slobodan Vukičević, David M. Reid, Steven R. Goldstein, Usha Sriram, Andy Lee, John R. Thompson, Róisín Armstrong, David D. Thompson, Trevor J. Powles, José Zanchetta, David L. Kendler, Patrick Neven, Richard Eastell
Cyhoeddwyd 2010Artigo -
20
Effects of CP-336,156, a New, Nonsteroidal Estrogen Agonist/Antagonist, on Bone, Serum Cholesterol, Uterus, and Body Composition in Rat Models gan Hua Zhu Ke, Vishwas Paralkar, W A Grasser, David T. Crawford, Hong Qi, Hollis A. Simmons, C.M. Pirie, Kristin L. Chidsey-Frink, Thomas A. Owen, Steven L. Smock, Hong Ka Chen, W.S.S. Jee, Kimberly O. Cameron, Robert L. Rosati, Thomas A. Brown, Paul DaSilva‐Jardine, David D. Thompson
Cyhoeddwyd 1998Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Internal medicine
Chemistry
Endocrinology
Biochemistry
Osteoporosis
Bone remodeling
Bone resorption
Enzyme
Alkaline phosphatase
Breast cancer
Calcium
Cancer
Biology
Bone density
Estrogen
Ovariectomized rat
Parathyroid hormone
Receptor
Bisphosphonate
Cell biology
Diphosphonates
Estrogen receptor
Hypophosphatasia
Kidney
Osteoclast
Phosphate
Surgery
Agonist
Alendronic acid